Evidence map›Paper›PMID 21832087›Full record

ArticleThe Journal of biological chemistry2011

Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).

Francisco Revert-Ros, Ernesto López-Pascual, Froilán Granero-Moltó, Jesús Macías, Richard Breyer, Roy Zent, Billy G Hudson, Anas Saadeddin, Fernando Revert, Raül Blasco and 3 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04626089 (Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb.), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04626089 phase2withdrawnstarted 2021, after this paper: background citation

Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb.

Ran2021Enrolled0Registered outcomes12Posted comparisons0ConditionsMetabolic Syndrome, Severe Acute Respiratory Syndrome Coronavirus 2, Type 2 DiabetesArmsMetformin glycinate, Placebo Oral Tablet
Open the trial in the graph
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Francisco Revert-RosCentro de Investigación Príncipe Felipe, 46012 Valencia, Spain.
Ernesto López-Pascual
Froilán Granero-Moltó
Jesús Macías
Richard Breyer
Roy Zent
Billy G Hudson
Anas Saadeddin
Fernando Revert
Raül Blasco
Carmen Navarro
Deborah Burks
Juan Saus
Centro de Investigacion Principe Felipe · ESVanderbilt University Medical Center · USUniversity Hospital Complex Of Vigo · ES

Funding

STUDIES ON THE STRUCTURE OF BASEMENT MEMBRANESR01DK018381 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Sergey Petrovich Budko, BILLY GERALD HUDSON · 1986 to 2026
$12.4M
STUDIES ON THE STRUCTURE OF BASEMENT MEMBRANESR37DK018381 · NIDDK · VANDERBILT UNIVERSITY · PI HUDSON, BILLY GERALD · 2000 to 2009
$4.5M
NIDDK NIH HHS DK18381NIDDK NIH HHS R01 DK018381NIDDK NIH HHS R37 DK018381
6 · The paper itself

Abstract

Goodpasture antigen-binding protein-1 (GPBP-1) is an exportable non-conventional Ser/Thr kinase that regulates glomerular basement membrane collagen organization. Here we provide evidence that GPBP-1 accumulates in the cytoplasm of differentiating mouse myoblasts prior to myosin synthesis. Myoblasts deficient in GPBP-1 display defective myofibril formation, whereas myofibrils assemble with enhanced efficiency in those overexpressing GPBP-1. We also show that GPBP-1 targets the previously unidentified GIP130 (GPBP-interacting protein of 130 kDa), which binds to myosin and promotes its myofibrillar assembly. This report reveals that GPBP-1 directs myofibril formation, an observation that expands its reported role in supramolecular organization of structural proteins to the intracellular compartment.

Indexed as

Gene Expression RegulationAnimalsBasement MembraneBlood ProteinsCarrier ProteinsCell LineCollagenDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMyoblastsMyofibrilsBlood ProteinsCarrier ProteinsCollagenDNA-Binding ProteinsFILIP1L protein, humanGoodpasture antigen-binding protein-1, mouseGPBP1 protein, humanGPBP-interacting protein of 130 kDa, mouseIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesRecombinant Proteins

Identifiers

PMID21832087
PMCPMC3186396
OpenAlexW2001602038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.